Literature DB >> 21387378

Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies.

S Veronica Tan1, Emma Matthews, Melissa Barber, James A Burge, Sanjeev Rajakulendran, Doreen Fialho, Richa Sud, Andrea Haworth, Martin Koltzenburg, Michael G Hanna.   

Abstract

OBJECTIVE: To improve the accuracy of genotype prediction and guide genetic testing in patients with muscle channelopathies we applied and refined specialized electrophysiological exercise test parameters.
METHODS: We studied 56 genetically confirmed patients and 65 controls using needle electromyography, the long exercise test, and short exercise tests at room temperature, after cooling, and rewarming.
RESULTS: Concordant amplitude-and-area decrements were more reliable than amplitude-only measurements when interpreting patterns of change during the short exercise tests. Concordant amplitude-and-area pattern I and pattern II decrements of >20% were 100% specific for paramyotonia congenita and myotonia congenita, respectively. When decrements at room temperature and after cooling were <20%, a repeat short exercise test after rewarming was useful in patients with myotonia congenita. Area measurements and rewarming distinguished true temperature sensitivity from amplitude reduction due to cold-induced slowing of muscle fiber conduction. In patients with negative short exercise tests, symptomatic eye closure myotonia predicted sodium channel myotonia over myotonia congenita. Distinctive "tornado-shaped" neuromyotonia-like discharges may be seen in patients with paramyotonia congenita. In the long exercise test, area decrements from pre-exercise baseline were more sensitive than amplitude decrements-from-maximum-compound muscle action potential (CMAP) in patients with Andersen-Tawil syndrome. Possible ethnic differences in the normative data of the long exercise test argue for the use of appropriate ethnically-matched controls.
INTERPRETATION: Concordant CMAP amplitude-and-area decrements of >20% allow more reliable interpretation of the short exercise tests and aid accurate DNA-based diagnosis. In patients with negative exercise tests, specific clinical features are helpful in differentiating sodium from chloride channel myotonia. A modified algorithm is suggested.
Copyright © 2011 American Neurological Association.

Entities:  

Mesh:

Year:  2011        PMID: 21387378      PMCID: PMC3051421          DOI: 10.1002/ana.22238

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

1.  Familial hypokalemic periodic paralysis in blacks.

Authors:  V A Corbett; F Q Nuttall
Journal:  Ann Intern Med       Date:  1975-07       Impact factor: 25.391

2.  The exercise test in periodic paralysis.

Authors:  P G McManis; E H Lambert; J R Daube
Journal:  Muscle Nerve       Date:  1986-10       Impact factor: 3.217

3.  Predictive value of the prolonged exercise test in hypokalemic paralytic attack.

Authors:  Y Arimura; K Arimura; S Suwazono; H Imamura; Y Sonoda; Y Maruyama; K Nakano; M Osame
Journal:  Muscle Nerve       Date:  1995-04       Impact factor: 3.217

Review 4.  Thyrotoxic hypokalemic periodic paralysis: report of four cases in black American males.

Authors:  R E Kilpatrick; S Seiler-Smith; S N Levine
Journal:  Thyroid       Date:  1994       Impact factor: 6.568

5.  Evoked response testing in myotonic syndromes.

Authors:  E W Streib
Journal:  Muscle Nerve       Date:  1984-09       Impact factor: 3.217

6.  Paramyotonia congenita: clinical and electrophysiologic studies.

Authors:  E W Streib; S F Sun; M Hanson
Journal:  Electromyogr Clin Neurophysiol       Date:  1983 May-Jun

7.  The exercise test in Andersen syndrome.

Authors:  J S Katz; G I Wolfe; S Iannaccone; W W Bryan; R J Barohn
Journal:  Arch Neurol       Date:  1999-03

8.  Exercise test in muscle channelopathies and other muscle disorders.

Authors:  T Kuntzer; F Flocard; C Vial; A Kohler; M Magistris; A Labarre-Vila; P M Gonnaud; F Ochsner; P Soichot; V Chan; G Monnier
Journal:  Muscle Nerve       Date:  2000-07       Impact factor: 3.217

Review 9.  AAEE minimonograph #27: differential diagnosis of myotonic syndromes.

Authors:  E W Streib
Journal:  Muscle Nerve       Date:  1987-09       Impact factor: 3.217

10.  The exercise test as a monitor of disease status in hypokalaemic periodic paralysis.

Authors:  C H Tengan; A C Antunes; A A Gabbai; G M Manzano
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

View more
  24 in total

Review 1.  Guidelines on clinical presentation and management of nondystrophic myotonias.

Authors:  Bas C Stunnenberg; Samantha LoRusso; W David Arnold; Richard J Barohn; Stephen C Cannon; Bertrand Fontaine; Robert C Griggs; Michael G Hanna; Emma Matthews; Giovanni Meola; Valeria A Sansone; Jaya R Trivedi; Baziel G M van Engelen; Savine Vicart; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2020-05-27       Impact factor: 3.217

2.  Clinical Utility Gene Card for: autosomal dominant myotonia congenita (Thomsen Disease).

Authors:  David J Coote; Mark R Davis; Macarena Cabrera; Merrilee Needham; Nigel G Laing; Kristen J Nowak
Journal:  Eur J Hum Genet       Date:  2018-04-26       Impact factor: 4.246

3.  Defective fast inactivation recovery of Nav 1.4 in congenital myasthenic syndrome.

Authors:  W David Arnold; Daniel H Feldman; Sandra Ramirez; Liuyuan He; Darine Kassar; Adam Quick; Tara L Klassen; Marian Lara; Joanna Nguyen; John T Kissel; Christoph Lossin; Ricardo A Maselli
Journal:  Ann Neurol       Date:  2015-03-27       Impact factor: 10.422

4.  Sodium Channel Myotonia and a Novel Gly701Asp Mutation in the SCN4A Gene: From an Ophthalmological Symptom to a Familial Disease.

Authors:  Filipa Sampaio; Sérgia Soares; Sara Pereira; José Alberto Lemos; Ágata Mota
Journal:  Neuroophthalmology       Date:  2020-07-24

Review 5.  Channelopathies of skeletal muscle excitability.

Authors:  Stephen C Cannon
Journal:  Compr Physiol       Date:  2015-04       Impact factor: 9.090

6.  A quantitative measure of handgrip myotonia in non-dystrophic myotonia.

Authors:  Jeffrey M Statland; Brian N Bundy; Yunxia Wang; Jaya R Trivedi; Dipa Raja Rayan; Laura Herbelin; Merideth Donlan; Rhonda McLin; Katy J Eichinger; Karen Findlater; Liz Dewar; Shree Pandya; William B Martens; Shannon L Venance; Emma Matthews; Anthony A Amato; Michael G Hanna; Robert C Griggs; Richard J Barohn
Journal:  Muscle Nerve       Date:  2012-10       Impact factor: 3.217

7.  Coexistence of CLCN1 and SCN4A mutations in one family suffering from myotonia.

Authors:  Lorenzo Maggi; Sabrina Ravaglia; Alessandro Farinato; Raffaella Brugnoni; Concetta Altamura; Paola Imbrici; Diana Conte Camerino; Alessandro Padovani; Renato Mantegazza; Pia Bernasconi; Jean-François Desaphy; Massimiliano Filosto
Journal:  Neurogenetics       Date:  2017-10-09       Impact factor: 2.660

Review 8.  Skeletal Muscle Channelopathies.

Authors:  Lauren Phillips; Jaya R Trivedi
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 9.  Muscle channelopathies: the nondystrophic myotonias and periodic paralyses.

Authors:  Jeffrey M Statland; Richard J Barohn
Journal:  Continuum (Minneap Minn)       Date:  2013-12

10.  In vivo assessment of muscle membrane properties in the sodium channel myotonias.

Authors:  S Veronica Tan; Werner J Z'Graggen; Michael G Hanna; Hugh Bostock
Journal:  Muscle Nerve       Date:  2017-09-23       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.